Lyme Disease Treatment - Injectable Bismacine is Potentially Harmful Warns FDA

Lyme disease should not be treated with injectable bismacine, also known as chromacine, according to a warning from the U.S. Food and Drug Administration (FDA). The compound, mixed by pharmacists, is not a pharmaceutical. Bismacine is an unapproved treatment for Lyme disease prescribed by some doctors of alternative health.

Bismacine, which contains large amounts of bismuth, is not approved for any use by injection. Severe side effects, including kidney failure and cardiovascular collapse, can result from its use. One death, one hospitalization, and several reports of adverse events are being investigated by the FDA.

Lyme disease is caused by an infection with the spirochete Borrelia burgdorferi which is transmitted by the bite of a deer tick. Lyme disease may be associated with a characteristic rash and result in complications which include arthritis, neurological symptoms, and heart problems.

Related Resources:

• Fast Facts About Lyme Disease
• Guide to Lyme Disease
• Lyme Disease Screening Quiz
• The Lyme Disease Photo Gallery
• Test Your Knowledge: Lyme Disease
• How to Protect Yourself Against Lyme Disease

_{Photo by Craig Smith (iStockphoto)}